Emergence of COVID-19 Is Expected to Augment the Apheresis Market Growth

 


Apheresis is an innovative medical procedure
where the blood is extracted from the patient's body and then desired blood components
(such as platelets, plasma, white cells, and red cells) are separated based on
their weight and size. Depending on the cause of apheresis, one of these
components is isolated and collected, while the other components are returned
to the body. Apheresis is a blood purification procedure performed for blood
donation component or for the treatment of disease.



It is performed for various diseases such as hematological,
autoimmune, renal, cardiovascular, neurological, and more. In the apheresis
procedure, the centrifuge therapeutic devices are used to separate desired
blood components from the donor’s blood. These blood components are separated based
on their characteristics such as affinity for substance, molecular weight, and size
among other factors.



Market
Dynamics



The emergence of COVID-19 is expected to
propel the growth
of the apheresis market. For instance, according to the Food and Drug
Control Administration (Gujarat, India), there were 13 plasma apheresis units
in the state before the pandemic, now the number has jumped to 28 to meet the
requirement of plasma used in convalescent plasma therapy. Moreover, worldwide,
as of 9:47am CET, 13 January 2021, there have been 90,054,813 confirmed cases
of COVID-19, including 1,945,610 deaths, according to the World Health
Organization (WHO).



Moreover, increasing prevalence or incidences
of chronic diseases, rising number of complex surgical procedures, increasing
demand for convalescent plasma therapy, and the favorable reimbursement policies
are also expected to drive the growth of the apheresis market.



The apheresis market is witnessing significant
M&A activities. For instance, in March 2020, Asahi Kasei Medical completed
acquisition of Veloxis Pharmaceuticals to expand its product portfolio and
strengthen its market position.



However, the high cost of apheresis treatment
and risk associated with apheresis such as anticoagulant reactions, infection,
and fluid transfer complications is expected to restrain the apheresis market
growth.



Competitive
Analysis



Major players active in the apheresis market
are HemaCare Corporation, B. Braun Melsungen AG, Therakos, Inc., Haemonetics
Corp., Fenwal Inc., Terumo BCT Inc., and Asahi Kasei Medical Co., Ltd.



Major players active in the market are
adopting various strategies such as business expansion to strengthen their
market position. For instance, in December 2020, Marken announced the launch of
two new facilities, such as a new pharmaceutical depot in Ukraine and apheresis
kit-building facility in the United States.


Comments

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more